Search Results - "Suvarna, Renuka"
-
1
Efficacy and safety of Resmetirom, a selective thyroid hormone receptor-β agonist, in the treatment of metabolic dysfunction-associated steatotic liver disease (MASLD): a systematic review and meta-analysis
Published in Scientific reports (26-08-2024)“…Metabolic dysfunction-associated steatotic liver disease (MASLD) is an important public health problem owing to its high prevalence and associated morbidity…”
Get full text
Journal Article -
2
The mechanistic role of neutrophil lymphocyte ratio perturbations in the leading non communicable lifestyle diseases [version 1; peer review: 2 approved]
Published in F1000 research (2022)“…Inflammation plays a critical role in the development and progression of chronic diseases like type 2 diabetes mellitus, coronary artery disease, and chronic…”
Get full text
Journal Article -
3
Effectiveness of polyherbal formulations for the treatment of type 2 Diabetes mellitus - A systematic review and meta-analysis
Published in Journal of ayurveda and integrative medicine (01-01-2021)“…The mortality and morbidity rate of diabetes patients is increasing worldwide which requires an ideal treatment to prevent the disease worsening. Traditional…”
Get full text
Journal Article -
4
Acute and sub-chronic toxicity of Liberin, an anti-diabetic polyherbal formulation in rats
Published in Journal of ayurveda and integrative medicine (01-11-2023)“…The polyherbal formulation (PHF) liberin, is known to exert anti-hyperglycemic effects in type 2 diabetes mellitus. Hence, it is important to study the safety…”
Get full text
Journal Article -
5
Anthropometric indices and type 2 diabetes mellitus as a risk factor in predicting nonalcoholic fatty liver disease - A prospective study in Indian population
Published in Indian journal of community medicine (01-07-2022)“…Background: The different anthropometric indices have different predictive values of nonalcoholic fatty liver disease (NAFLD) in various populations. Since…”
Get full text
Journal Article -
6
Efficacy and safety of once‐weekly insulin icodec in type 2 diabetes: A meta‐analysis of ONWARDS phase 3 randomized controlled trials
Published in Diabetes, obesity & metabolism (01-03-2024)“…Aim Insulin icodec is a novel ultra‐long action basal insulin analogue designed for once‐weekly administration. With the merit of once‐a‐week administration,…”
Get full text
Journal Article -
7
Serum paraoxonase 1 activity status in patients with liver disorders
Published in Saudi journal of gastroenterology (01-04-2010)“…Paraoxonase 1 (PON1) is an esterase, exclusively synthesized by liver. The present study has two objectives: to determine the PON1 activity status in various…”
Get full text
Journal Article -
8
HDL or hs-CRP: The Prognostic Conundrum in Acute Coronary Syndrome
Published in Indian journal of clinical biochemistry (18-11-2024)Get full text
Journal Article